Cargando…
Should we initiate vasopressors earlier in patients with septic shock: A mini systemic review
Septic shock treatment remains a major challenge for intensive care units, despite the recent prominent advances in both management and outcomes. Vasopressors serve as a cornerstone of septic shock therapy, but there is still controversy over the timing of administration. Specifically, it remains un...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10515096/ https://www.ncbi.nlm.nih.gov/pubmed/37745258 http://dx.doi.org/10.5492/wjccm.v12.i4.204 |
_version_ | 1785108873961537536 |
---|---|
author | Zhou, Hang-Xiang Yang, Chun-Fu Wang, He-Yan Teng, Yin He, Hang-Yong |
author_facet | Zhou, Hang-Xiang Yang, Chun-Fu Wang, He-Yan Teng, Yin He, Hang-Yong |
author_sort | Zhou, Hang-Xiang |
collection | PubMed |
description | Septic shock treatment remains a major challenge for intensive care units, despite the recent prominent advances in both management and outcomes. Vasopressors serve as a cornerstone of septic shock therapy, but there is still controversy over the timing of administration. Specifically, it remains unclear whether vasopressors should be used early in the course of treatment. Here, we provide a systematic review of the literature on the timing of vasopressor administration. Research was systematically identified through PubMed, Embase and Cochrane searching according to PRISMA guidelines. Fourteen studies met the eligibility criteria and were included in the review. The pathophysiological basis for early vasopressor use was classified, with the exploration on indications for the early administration of mono-vasopressors or their combination with vasopressin or angiotensinII. We found that mortality was 28.1%-47.7% in the early vasopressors group, and 33.6%-54.5% in the control group. We also investigated the issue of vasopressor responsiveness. Furthermore, we acknowledged the subsequent challenge of administration of high-dose norepinephrine via peripheral veins with early vasopressor use. Based on the literature review, we propose a possible protocol for the early initiation of vasopressors in septic shock resuscitation. |
format | Online Article Text |
id | pubmed-10515096 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Baishideng Publishing Group Inc |
record_format | MEDLINE/PubMed |
spelling | pubmed-105150962023-09-23 Should we initiate vasopressors earlier in patients with septic shock: A mini systemic review Zhou, Hang-Xiang Yang, Chun-Fu Wang, He-Yan Teng, Yin He, Hang-Yong World J Crit Care Med Minireviews Septic shock treatment remains a major challenge for intensive care units, despite the recent prominent advances in both management and outcomes. Vasopressors serve as a cornerstone of septic shock therapy, but there is still controversy over the timing of administration. Specifically, it remains unclear whether vasopressors should be used early in the course of treatment. Here, we provide a systematic review of the literature on the timing of vasopressor administration. Research was systematically identified through PubMed, Embase and Cochrane searching according to PRISMA guidelines. Fourteen studies met the eligibility criteria and were included in the review. The pathophysiological basis for early vasopressor use was classified, with the exploration on indications for the early administration of mono-vasopressors or their combination with vasopressin or angiotensinII. We found that mortality was 28.1%-47.7% in the early vasopressors group, and 33.6%-54.5% in the control group. We also investigated the issue of vasopressor responsiveness. Furthermore, we acknowledged the subsequent challenge of administration of high-dose norepinephrine via peripheral veins with early vasopressor use. Based on the literature review, we propose a possible protocol for the early initiation of vasopressors in septic shock resuscitation. Baishideng Publishing Group Inc 2023-09-09 /pmc/articles/PMC10515096/ /pubmed/37745258 http://dx.doi.org/10.5492/wjccm.v12.i4.204 Text en ©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. https://creativecommons.org/licenses/by-nc/4.0/This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. |
spellingShingle | Minireviews Zhou, Hang-Xiang Yang, Chun-Fu Wang, He-Yan Teng, Yin He, Hang-Yong Should we initiate vasopressors earlier in patients with septic shock: A mini systemic review |
title | Should we initiate vasopressors earlier in patients with septic shock: A mini systemic review |
title_full | Should we initiate vasopressors earlier in patients with septic shock: A mini systemic review |
title_fullStr | Should we initiate vasopressors earlier in patients with septic shock: A mini systemic review |
title_full_unstemmed | Should we initiate vasopressors earlier in patients with septic shock: A mini systemic review |
title_short | Should we initiate vasopressors earlier in patients with septic shock: A mini systemic review |
title_sort | should we initiate vasopressors earlier in patients with septic shock: a mini systemic review |
topic | Minireviews |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10515096/ https://www.ncbi.nlm.nih.gov/pubmed/37745258 http://dx.doi.org/10.5492/wjccm.v12.i4.204 |
work_keys_str_mv | AT zhouhangxiang shouldweinitiatevasopressorsearlierinpatientswithsepticshockaminisystemicreview AT yangchunfu shouldweinitiatevasopressorsearlierinpatientswithsepticshockaminisystemicreview AT wangheyan shouldweinitiatevasopressorsearlierinpatientswithsepticshockaminisystemicreview AT tengyin shouldweinitiatevasopressorsearlierinpatientswithsepticshockaminisystemicreview AT hehangyong shouldweinitiatevasopressorsearlierinpatientswithsepticshockaminisystemicreview |